BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7049175)

  • 41. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation.
    Oseas RS; Boxer LA; Butterick C; Baehner RL
    J Lab Clin Med; 1980 Aug; 96(2):213-21. PubMed ID: 7400660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemotactic receptor of cord blood granulocytes to the synthesized chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Nunoi H; Endo F; Chikazawa S; Namikawa T; Matsuda I
    Pediatr Res; 1983 Jan; 17(1):57-60. PubMed ID: 6300743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FMLP-induced enzyme release from neutrophils: a role for intracellular calcium.
    Chandler D; Meusel G; Schumaker E; Stapleton C
    Am J Physiol; 1983 Sep; 245(3):C196-202. PubMed ID: 6412560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel leukotriene produced by stimulation of leukocytes with formylmethionylleucylphenylalanine.
    Jubiz W; Rådmark O; Malmsten C; Hansson G; Lindgren JA; Palmblad J; Udén AM; Samuelsson B
    J Biol Chem; 1982 Jun; 257(11):6106-10. PubMed ID: 6281258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D; Roloff JS; Lukens JN
    J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
    [No Abstract]   [Full Text] [Related]  

  • 47. The roles of degranulation and superoxide anion generation in neutrophil aggregation.
    Kaplan HB; Edelson HS; Friedman R; Weissmann G
    Biochim Biophys Acta; 1982 Sep; 721(1):55-63. PubMed ID: 6289915
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotaxis of endothelial cells to formyl-methionyl-leucyl-phenylalanine.
    Hoover RL; Wright TC
    Microvasc Res; 1983 Jul; 26(1):122-5. PubMed ID: 6888282
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.
    Fearon DT; Collins LA
    J Immunol; 1983 Jan; 130(1):370-5. PubMed ID: 6847888
    [No Abstract]   [Full Text] [Related]  

  • 50. Demonstration of calcium-dependent chemotactic factor activatable esterase activity in human neutrophils: relationship with chemotaxis and chemotactic deactivation.
    Mehta J; Mandell B; Kleyman T; Spilberg I
    Inflammation; 1981 Jun; 5(2):89-101. PubMed ID: 7275278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytoplasmic microtubules in polymorphonuclear leukocytes: effects of chemotactic stimulation and colchicine.
    Anderson DC; Wible LJ; Hughes BJ; Smith CW; Brinkley BR
    Cell; 1982 Dec; 31(3 Pt 2):719-29. PubMed ID: 7159932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of several chemotactic peptide antagonists.
    Day AR; Pinon D; Muthukumaraswamy N; Freer RJ
    Peptides; 1980; 1(4):289-91. PubMed ID: 7301634
    [No Abstract]   [Full Text] [Related]  

  • 53. Lipomodulin: a possible mediator of the action of glucocorticoids.
    Hirata F
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():73-8. PubMed ID: 6221579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A reevaluation of the chemotactic potency of leukotriene B4 (LTB4).
    Jubiz W
    Biochem Biophys Res Commun; 1983 Feb; 110(3):842-50. PubMed ID: 6301465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.
    Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):443-9. PubMed ID: 7085067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins.
    Van Epps DE; Brown SL
    Infect Immun; 1981 Dec; 34(3):864-70. PubMed ID: 7333672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotactic factor-induced release of membrane calcium in rabbit neutrophils.
    Naccache PH; Volpi M; Showell HJ; Becker EL; Sha'afi RI
    Science; 1979 Feb; 203(4379):461-3. PubMed ID: 760200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotaxis in vitreous haemorrhage: an experimental study.
    LaNauze JH; Hembry RM; Jacobson W; Watson PG
    Exp Eye Res; 1982 May; 34(5):803-13. PubMed ID: 7084341
    [No Abstract]   [Full Text] [Related]  

  • 60. Response of adenosine cyclic 3',5'-monophosphate level in rabbit neutrophils to the chemotactic peptide formyl-methionyl-leucyl-phenylalanine.
    Jackowski S; Sha'afi RI
    Mol Pharmacol; 1979 Sep; 16(2):473-81. PubMed ID: 229400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.